On 9 October 2026, Purapharm Corporation Limited announced the release of its Extraordinary General Meeting (EGM) circular, meeting notice and proxy form in both English and Chinese. The documents are now accessible on the HKEXnews website and the company’s own site. Printed copies remain available free of charge upon request to Computershare Hong Kong Investor Services Limited.

Purapharm confirmed that it has formally adopted the electronic dissemination framework permitted under Hong Kong Listing Rule 2.07, which took effect on 31 December 2023. All future corporate communications—including annual and interim reports, circulars, meeting notices, listing documents and proxy forms—will be distributed electronically unless shareholders explicitly request hard copies.

To ensure prompt notification of future releases, shareholders are encouraged to submit a functional email address by scanning the personalised QR code on the reply form or by returning the completed form to the share registrar. Those who do not provide an email address must monitor the company and HKEXnews websites for updates; only “actionable” documents will be mailed to them in printed form.

Shareholders opting for hard-copy communications can do so by completing the reply form or emailing purapharm.ecom@computershare.com.hk. This request will remain valid for one year from the date of receipt. For enquiries, investors may contact the share registrar on +852 2862 8688 during Hong Kong business hours.